CytoMed Therapeutics reported total assets of $6.16M and total liabilities of $0.87M for the quarter ended Dec 2025, down 32.8% year over year. This balance sheet covers 9 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current Assets | |||||||||
| Cash & EquivalentsCash & Equiv. | 1.85M | 2.51M | 1.14M | 10.44M | 6.66M | 9.00M | 3.74M | 2.85M | 1.62M |
| Short-term InvestmentsInvestments (Current) | 0.05M | 5.20M | |||||||
| Cash & Current Investments | 1.85M | 2.51M | 1.18M | 10.44M | 11.86M | 9.00M | 3.74M | 2.85M | 1.62M |
| Receivables | 0.58M | 0.71M | 1.01M | 1.15M | 1.31M | 1.59M | |||
| Loans - Net | 2.31M | 3.40M | |||||||
| Prepaid Assets | 0.04M | 0.19M | |||||||
| Current Assets | 2.42M | 1.80M | 11.47M | 7.48M | 7.71M | 4.51M | 4.08M | 2.83M | |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment (Net) | 2.06M | 1.97M | 0.43M | 1.68M | 0.39M | 3.06M | 3.33M | ||
| Long-Term Investments | 0.27M | 0.24M | 0.22M | 0.20M | 0.21M | 0.22M | 0.21M | ||
| Intangibles | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.07M | 0.10M | |
| Goodwill & Intangibles | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.07M | 0.10M | |
| Other Non-Current Assets | 0.50M | 0.03M | 0.03M | ||||||
| Non-Current Assets | 2.06M | 1.97M | 2.45M | 1.68M | 3.20M | 3.06M | 4.27M | 3.33M | |
| Assets | 4.48M | 3.77M | 13.91M | 9.16M | 10.91M | 7.57M | 8.36M | 6.16M | |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payables | 0.16M | 0.30M | 0.27M | 0.39M | 0.32M | 0.33M | 0.48M | 0.34M | |
| Notes Payables | 0.28M | 0.24M | 0.03M | 0.03M | 0.03M | ||||
| Payables | 0.45M | 0.54M | 0.27M | 0.41M | 0.32M | 0.36M | 0.48M | 0.37M | |
| Short term Debt | 0.28M | 0.24M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | ||
| Current Leases | 0.02M | 0.01M | 0.02M | 0.06M | 0.05M | ||||
| Current Taxes | 0.00M | 0.43M | 0.41M | 0.39M | |||||
| Current Deferred Revenue | 0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 0.11M | 0.08M | 0.18M | |
| Total Current Liabilities | 2.16M | 3.00M | 0.31M | 0.53M | 0.36M | 0.46M | 0.70M | 0.55M | |
| Non-Current Liabilities | |||||||||
| Non-Current Debt | 0.40M | 0.34M | 0.04M | 0.30M | 0.04M | 0.30M | 0.04M | 0.28M | |
| Minority Interest | -439.00 | -682.00 | -822.00 | -956.00 | -0.00M | 0.08M | 0.08M | 0.31M | |
| Operating Leases | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | 0.02M | 0.02M | 0.04M | |
| Other Non-Current Liabilities | 0.11M | 0.01M | 0.09M | 0.02M | |||||
| Total Non-Current Liabilities | 0.41M | 0.34M | 0.43M | 0.30M | 0.39M | 0.31M | 0.43M | 0.33M | |
| Total Liabilities | 2.57M | 3.34M | 0.75M | 0.83M | 0.75M | 0.77M | 1.13M | 0.87M | |
| Shareholder's Equity | |||||||||
| Total Debt | 0.97M | 0.82M | 0.07M | 0.35M | 0.07M | 0.35M | 0.04M | 0.35M | |
| Common Equity | 1.91M | 0.42M | 13.17M | 8.33M | 10.16M | 6.80M | 7.22M | 5.29M | |
| Liabilities and Shareholders Equity | 4.48M | 3.77M | 13.91M | 9.16M | 10.91M | 7.57M | 8.36M | 6.16M | |
| Retained Earnings | -3.73M | -5.91M | -10.36M | -9.13M | -13.42M | -11.16M | -17.09M | -14.53M |